www.vigilneuro.com Open in urlscan Pro
198.49.23.145  Public Scan

Form analysis
0 forms found in the DOM

Text Content

About Us Science Programs Patients Investors Careers

Back Who We Are Team Board of Directors Scientific Advisory Board Contact Us
Back Roles of Microglia in CNS TREM2 as a Therapeutic Target Publications
Back Strategy Pipeline Clinical Trials
Back Patients & Caregivers
Back Overview Press Releases Events & Presentations Stock Information Financials
& Filings Governance IR Resources
Back Join Us! Current Opportunities
Back Documents & Charters Leadership Board of Directors Committee Composition
Back FAQs Email Alerts Contact IR


About Us Who We Are Team Board of Directors Scientific Advisory Board Contact Us
Science Roles of Microglia in CNS TREM2 as a Therapeutic Target Publications
Programs Strategy Pipeline Clinical Trials Patients Patients & Caregivers
Investors Overview Press Releases Events & Presentations Stock Information
Financials & Filings Governance Documents & Charters Leadership Board of
Directors Committee Composition IR Resources FAQs Email Alerts Contact IR
Careers Join Us! Current Opportunities

Scroll

 


HARNESSING THE POWER OF MICROGLIA




TO IMPROVE THE LIVES OF PATIENTS, CAREGIVERS AND FAMILIES THROUGH TRANSFORMATIVE
TREATMENTS FOR NEURODEGENERATIVE DISEASES

Learn more
 

Vigil Neuroscience is a microglia-focused therapeutics company

Our purpose is clear: to treat rare and common neurodegenerative diseases by
restoring the vigilance of microglia, the brain’s sentinel immune cells. We are
harnessing the tools of modern neuroscience to develop and deliver
precision-based therapies to improve the lives of patients and their families.

LEARN MORE

 

 


OUR APPROACH

Leveraging recent discoveries implicating the pivotal role of microglial
dysfunction in neurodegenerative diseases, we are applying a precision medicine
approach to develop novel microglia-targeted drug candidates for genetically
defined patient subpopulations. Our goal ultimately is to develop therapies for
larger patient populations, leveraging learnings from our initial
precision-based programs.

Learn more
 
 
 


OUR PROGRAMS

Our most advanced therapeutic programs are aimed at developing highly selective
activators of TREM2, a membrane spanning receptor expressed specifically on
microglia, resident immune sentinel cells in the brain. TREM2 plays a critical
role in maintaining brain homeostasis, as highlighted by inherited
neurodegenerative diseases associated with TREM2 dysfunction.

Learn more
 
 
 


PATIENTS

Patients are central to our primary objective of developing drugs for rare and
common neurodegenerative diseases. Our approach is to collaborate with patients,
caregivers, and patient advocacy groups to best serve the patient community.

Learn more
 
 
Banner

About

Approach

Programs

Patients
 

One Broadway
Suite 07-300
Cambridge, MA 02142

+1 857 254 4445
info@vigilneuro.com



ABOUT US
SCIENCE
PATIENTS
INVESTORS
CAREERS

©2021 Vigil Neuroscience, Inc.
PRIVACY POLICY | TERMS OF SERVICE

Vigil Neuroscience, Inc.
400 Technology Square, 10th Floor,
Cambridge, MA, 02139,
United States
Info@vigilneuro.com
Hours
Mon 8am - 5pm
Tue 8am - 5pm
Wed 8am - 5pm
Thu 8am - 5pm
Fri 8am - 5pm

 

Exit

You are leaving Vigil Neuroscience, Inc.’s website. You may return to Vigil
Neuroscience, Inc.’s website by using the “Back” button on your Web browser
toolbar or closing the window to the third-party website that you have opened.
Do you wish to continue?

 

Yes
No